A Multifaceted Intervention on Reducing Immunization Errors (THEIA)

February 7, 2025 updated by: Hospital Israelita Albert Einstein

A Multifaceted Intervention on Reducing Immunization Errors: a Pragmatic, Stepped-wedge, Cluster Randomized Trial

The goal of this trial is to reduce the general error related to vaccines and immunizations (composited on secondary endpoint), after 11 moths of folow-up after cluster randomization and stepped wedge on primary care on brazilian public health.

The main questions it aims to answer are:

  1. To evaluate the effectiveness of a multifaceted intervention in vaccination rooms in reducing vaccination errors.
  2. To describe the rate of adverse events following immunization (AEFI) and the associated factors.

Study Overview

Detailed Description

Researchers will compare two times in a Stepped Wedge design:

  1. Usual Care :All sites will follow the standard practices for vaccine management and immunization in health units with vaccination rooms during 1 month.

    All sites will be randomized into 11 steps (corresponding to the number of stages required to complete the 12-month study). At each step, 8 clusters (each containing one immunization service within a primary care facility) will receive the intervention."

  2. Multifaceted Strategy :*This time will implement a multifaceted quality improvement and process strategy composed of:

    • Video-based training on vaccine management.
    • Development of an optimized Cold Chain Manual, streamlining guidelines for vaccine handling.
    • Technical documents providing comprehensive guidance on the appropriate management of vaccines and their respective immunization schedules.
    • Technical documentsaddressing the management of errors identified post-vaccination and offering recommendations for public guidance.

Study Type

Interventional

Enrollment (Estimated)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Cluster Inclusion Criteria

  • Health units with vaccination rooms administering at least 2,000 doses of vaccines/immunobiologicals per month,

Cluster Exclusion Criteria

  • Primary health units that do not provide consistent vaccination services to the population.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Usual Care Group
This arm will continue to follow the routine activities and standard procedures established by the public health system.
Usual care for immunizations.
Other: Multifaceted Intervention Group

This group will implement a multifaceted quality improvement and process strategy composed of:

Video-based training on vaccine management. Development of an optimized Cold Chain Manual, streamlining guidelines for vaccine handling.

Technical documents providing comprehensive guidance on the appropriate management of vaccines and their respective immunization schedules.

Technical documents addressing the management of errors identified post-vaccination and offering recommendations for public guidance

The multifaceted quality improvement intervention includes: video-based training on vaccine management in SUS, an optimized Cold Chain Manual schema, technical documents on proper vaccine handling and immunization schedules, and checklists for managing post-vaccination errors and corrective procedures. Videos will focus on six key points (right person, vaccine, dose, time, route, and documentation), with each lasting about 2 minutes and accessible on-demand. The Cold Chain schema will cover storage, monitoring, transport, conservation, and handling, with checklists for each category. Standardized technical documents will align with video themes, ensuring protocol adherence. An error identification and management schema will address issues like improper vaccine administration, cold chain violations, and incorrect dosages. This schema will be reviewed by staff and made available in health units.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reduction of overall errors attributable to vaccination and immunization processes.
Time Frame: From Randomization to the end of Follow-up (12 months)
The primary composite outcome is defined as the reduction of overall errors attributable to vaccination and immunization processes, including: dilution errors, administration of vaccines outside the recommended age, errors related to inappropriate intervals between doses/vaccines, errors in the use of immunobiologicals, errors related to repeated doses, administration of vaccines not recommended during pregnancy, errors in the storage and handling of vaccines and immunobiologicals, and administration of vaccines via incorrect routes.
From Randomization to the end of Follow-up (12 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence of the components of the primary outcome
Time Frame: Through study completion, an average of 1 year
Rate of the components of the primary outcome.
Through study completion, an average of 1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary Secondary Outcome - Incidence of reported Adverse Events Following Immunization
Time Frame: From Randomization to the end of Follow-up (12 months)
Incidence of reported Adverse Events Following Immunization (AEFI) in the studied health units-AEFIs recorded either spontaneously or through active surveillance within the health units during the study period.
From Randomization to the end of Follow-up (12 months)
Exploratory Objective - Economical impact of strategy for reduce the error of immunization
Time Frame: Through study completion, an average of 1 year
Cost-Effectiveness - Economical impact of strategy for reduce the error of immunization as basis for public vaccination policy justification -
Through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Henrique A Fonseca, ScD, PhD, Hospital Albert Einstein

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 3, 2025

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

December 30, 2026

Study Registration Dates

First Submitted

December 11, 2024

First Submitted That Met QC Criteria

December 17, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 7, 2025

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vaccines

Clinical Trials on Usual Care

Subscribe